Egaba 50 mg (Capsule)
Unit Price: ৳ 14.00 (3 x 10: ৳ 420.00)
Strip Price: ৳ 140.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Euro pharma ltd |
| Also available as |
Indications
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
Pharmacology
- Structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
- Binds with high affinity to the alpha2-delta site in central nervous system tissues
- Results in animal studies suggest anti-nociceptive and antiseizure effects
Dosage
- Maximum recommended dose of Pregabalin for neuropathic pain associated with diabetic peripheral neuropathy is 100 mg three times a day
- Recommended dose of Pregabalin for postherpetic neuralgia is 75 to 150 mg two times a day or 50 to 100 mg three times a day
- Recommended dose of Pregabalin for fibromyalgia is 300 to 450 mg/day
- Recommended dose range of Pregabalin for neuropathic pain associated with spinal cord injury is 150 to 600 mg/day
Administration
- Oral route of administration
- Can be taken with or without food
- Pregabalin CR tablet should be administered after an evening meal
- Should be swallowed whole and should not be split, crushed or chewed
Interaction
- Egaba is unlikely to be involved in significant pharmacokinetic drug interactions
- Not applicable drug interaction with food and others
Contraindications
- Contraindicated in patients with known hypersensitivity to Pregabalin or any of its components
Side Effects
- Most common side effects in adults: dizziness, somnolence, dry mouth, edema, blurred vision, weight gain, and thinking abnormal
- Most common side effects in pediatric patients for the treatment of partial onset seizures: increased weight and increased appetite
Pregnancy & Lactation
- No adequate and well-controlled studies with pregabalin in pregnant women
- Small amounts of pregabalin detected in the milk of lactating women
- Breastfeeding not recommended during treatment with pregabalin
Precautions & Warnings
- Angioedema, hypersensitivity reactions, and respiratory depression may occur
- Increased risk of suicidal thoughts or behavior
- May cause dizziness, somnolence, and impair ability to drive or operate machinery
- Increased seizure frequency or other adverse reactions may occur if rapidly discontinued
Use in Special Populations
- Safety and effectiveness not established in pediatric patients for various conditions
- Safety and effectiveness of Egaba extended-release tablet not established in pediatric patients
Overdose Effects
- Signs and symptoms include reduced consciousness, depression/anxiety, confusional state, agitation, restlessness, seizures, and heart block
- No specific antidote
- General supportive care of the patient is indicated
Therapeutic Class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C8H17NO2
- Chemical Structure image available
Common Questions
- What is Egaba 50 mg Capsule?
- How long do I need to use Egaba 50 mg Capsule before I see improvement in my condition?
- At what frequency do I need to use Egaba 50 mg Capsule?
- Should I use Egaba 50 mg Capsule empty stomach, before food or after food?
- Instructions for the storage and disposal of Egaba 50 mg Capsule
- Does Egaba 50 mg Capsule work in the same way for each disease?
- How long do I need to take Egaba 50 mg Capsule?
- Is it necessary to continue taking Egaba 50 mg Capsule even if I feel fine?
- Can I take Diazepam and Egaba 50 mg Capsule together?
- Can the use of Egaba 50 mg Capsule cause weight gain?
- Quick Tips for Egaba 50 mg Capsule